Abstract
Thrombolytic therapy is an effective method for reopening an occluded venous segment, but little is known about the long-term results of thrombolysis via direct intravenous route for axillary subclavian vein thrombosis (ASVT). Our experience with 13 cases of primary ASVT illustrates the possible advantages of a protocol consisting of lytic therapy, surgical decompression and percutaneous balloon angioplasty if a high-grade stenosis persists. If accompanied by adjunctive therapy to correct the underlying cause, thrombolytic therapy for ASVT results in acceptable long-term symptom relief and vein patency.
MeSH terms
-
Adult
-
Aged
-
Angioplasty, Balloon / methods*
-
Anticoagulants / therapeutic use
-
Axilla / blood supply*
-
Causality
-
Clinical Protocols
-
Combined Modality Therapy
-
Female
-
Follow-Up Studies
-
Hot Temperature / therapeutic use
-
Humans
-
Infusions, Intravenous
-
Male
-
Middle Aged
-
Phlebography
-
Streptokinase / therapeutic use*
-
Subclavian Vein*
-
Thrombectomy / methods*
-
Thrombolytic Therapy / methods*
-
Thrombosis / classification
-
Thrombosis / diagnostic imaging
-
Thrombosis / epidemiology
-
Thrombosis / therapy*
-
Treatment Outcome
-
Urokinase-Type Plasminogen Activator / therapeutic use*
-
Vascular Patency
-
Veins / transplantation
Substances
-
Anticoagulants
-
Streptokinase
-
Urokinase-Type Plasminogen Activator